We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Charity Commission is seeking your views on the charitable status of complementary and alternative medicines.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The committee advises on the safety and quality of herbal medicines when there's an application for registration, marketing authorisation or product licence.
An organisation offering alternative therapies to people living with cancer has decided to wind up and be removed from the register of charities, after the Charity Commission challenged its public benefit.
This consultation explores whether changes to the tax treatment of companies used by funds to hold assets could make the UK a more attractive location for these companies.
The Competition and Markets Authority (CMA) has produced this guide to help you understand what your main consumer law rights are at the different stages of considering and undergoing fertility treatment.
How to use a cost utility analysis to evaluate your digital health product.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
Read about talking therapies and counselling for mental health problems.
How to use a cost effectiveness analysis to evaluate your digital health product.
The rules for ensuring patients’ referral to treatment (RTT) waiting time, for consultant-led treatment, is fair and consistent within an 18-week period.
Information on accessing healthcare for visitors to the UK from EU countries, Norway, Iceland, Liechtenstein and Switzerland.
New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review
How to use a randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.